HEADER VIRAL PROTEIN/INHIBITOR 20-FEB-23 8IG5 TITLE CRYSTAL STRUCTURE OF SARS MAIN PROTEASE IN COMPLEX WITH GC376 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE NSP5; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3CL-PRO,3CLP,MAIN PROTEASE,MPRO,NON-STRUCTURAL PROTEIN 5, COMPND 5 NSP5,SARS CORONAVIRUS MAIN PROTEINASE; COMPND 6 EC: 3.4.22.69; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME-RELATED SOURCE 3 CORONAVIRUS; SOURCE 4 ORGANISM_TAXID: 694009; SOURCE 5 GENE: 1A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS VIRAL PROTEIN-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.LIN,J.ZHANG,J.LI REVDAT 2 08-MAY-24 8IG5 1 JRNL REVDAT 1 06-MAR-24 8IG5 0 JRNL AUTH C.LIN,Z.ZHU,H.JIANG,X.ZOU,X.ZENG,J.WANG,P.ZENG,W.LI,X.ZHOU, JRNL AUTH 2 J.ZHANG,Q.WANG,J.LI JRNL TITL STRUCTURAL BASIS FOR CORONAVIRAL MAIN PROTEASES INHIBITION JRNL TITL 2 BY THE 3CLPRO INHIBITOR GC376. JRNL REF J.MOL.BIOL. V. 436 68474 2024 JRNL REFN ESSN 1089-8638 JRNL PMID 38311236 JRNL DOI 10.1016/J.JMB.2024.168474 REMARK 2 REMARK 2 RESOLUTION. 2.17 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.12_2829 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.17 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.93 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.968 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.1 REMARK 3 NUMBER OF REFLECTIONS : 40305 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.873 REMARK 3 FREE R VALUE TEST SET COUNT : 1964 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.9200 - 5.2205 0.95 2768 158 0.1824 0.1898 REMARK 3 2 5.2205 - 4.1457 0.96 2853 122 0.1714 0.1978 REMARK 3 3 4.1457 - 3.6222 0.96 2821 141 0.1958 0.2475 REMARK 3 4 3.6222 - 3.2913 0.96 2828 154 0.2199 0.2535 REMARK 3 5 3.2913 - 3.0555 0.97 2850 139 0.2313 0.2687 REMARK 3 6 3.0555 - 2.8754 0.97 2866 157 0.2381 0.2704 REMARK 3 7 2.8754 - 2.7315 0.97 2852 149 0.2387 0.3258 REMARK 3 8 2.7315 - 2.6126 0.97 2823 157 0.2524 0.2731 REMARK 3 9 2.6126 - 2.5121 0.97 2838 143 0.2413 0.2983 REMARK 3 10 2.5121 - 2.4254 0.97 2843 153 0.2450 0.2624 REMARK 3 11 2.4254 - 2.3496 0.97 2854 136 0.2636 0.2646 REMARK 3 12 2.3496 - 2.2824 0.96 2817 149 0.2775 0.3114 REMARK 3 13 2.2824 - 2.2223 0.50 1492 62 0.2923 0.3398 REMARK 3 14 2.2223 - 2.1700 0.96 2836 144 0.3139 0.2948 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.256 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.626 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 42.35 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.07 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4496 REMARK 3 ANGLE : 1.020 6132 REMARK 3 CHIRALITY : 0.053 715 REMARK 3 PLANARITY : 0.006 796 REMARK 3 DIHEDRAL : 4.571 2671 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8IG5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 01-MAR-23. REMARK 100 THE DEPOSITION ID IS D_1300035158. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-SEP-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL02U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 S 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40341 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.170 REMARK 200 RESOLUTION RANGE LOW (A) : 57.170 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.04400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.17 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.29 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.40400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES PH7.5, 10% PEG8000, 8% REMARK 280 ETHYLENE GLYCOL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1900 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24610 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 2 REMARK 465 PHE A 3 REMARK 465 CYS A 300 REMARK 465 ALA B 46 REMARK 465 GLU B 47 REMARK 465 ASP B 48 REMARK 465 MET B 49 REMARK 465 CYS B 300 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 47 CG CD OE1 OE2 REMARK 470 MET A 49 CG SD CE REMARK 470 ASN A 51 CG OD1 ND2 REMARK 470 LEU A 57 CG CD1 CD2 REMARK 470 HIS A 64 CG ND1 CD2 CE1 NE2 REMARK 470 LEU A 67 CG CD1 CD2 REMARK 470 ASN A 72 CG OD1 ND2 REMARK 470 GLN A 74 CG CD OE1 NE2 REMARK 470 ARG A 76 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 78 CG1 CG2 CD1 REMARK 470 LYS A 90 CG CD CE NZ REMARK 470 VAL A 91 CG1 CG2 REMARK 470 LYS A 100 CG CD CE NZ REMARK 470 ASP A 153 CG OD1 OD2 REMARK 470 TYR A 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP A 155 CG OD1 OD2 REMARK 470 LYS A 180 CG CD CE NZ REMARK 470 ARG A 222 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 227 CG CD1 CD2 REMARK 470 ASP A 229 CG OD1 OD2 REMARK 470 LEU A 232 CG CD1 CD2 REMARK 470 VAL A 233 CG1 CG2 REMARK 470 LYS A 236 CG CD CE NZ REMARK 470 ASP A 245 CG OD1 OD2 REMARK 470 GLN A 256 CG CD OE1 NE2 REMARK 470 LYS A 269 CG CD CE NZ REMARK 470 GLU A 270 CG CD OE1 OE2 REMARK 470 GLN A 273 CG CD OE1 NE2 REMARK 470 ARG A 279 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 288 CG CD OE1 OE2 REMARK 470 PHE A 291 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 298 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 3 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU B 50 CG CD1 CD2 REMARK 470 ASN B 51 CG OD1 ND2 REMARK 470 HIS B 64 CG ND1 CD2 CE1 NE2 REMARK 470 LEU B 67 CG CD1 CD2 REMARK 470 ASN B 72 CG OD1 ND2 REMARK 470 GLN B 74 CG CD OE1 NE2 REMARK 470 LEU B 75 CG CD1 CD2 REMARK 470 ARG B 76 CG CD NE CZ NH1 NH2 REMARK 470 VAL B 77 CG1 CG2 REMARK 470 ILE B 78 CG1 CG2 CD1 REMARK 470 LYS B 90 CG CD CE NZ REMARK 470 VAL B 91 CG1 CG2 REMARK 470 LYS B 97 CG CD CE NZ REMARK 470 LYS B 100 CG CD CE NZ REMARK 470 ASN B 142 CG OD1 ND2 REMARK 470 ASP B 153 CG OD1 OD2 REMARK 470 TYR B 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP B 155 CG OD1 OD2 REMARK 470 LYS B 180 CG CD CE NZ REMARK 470 THR B 190 OG1 CG2 REMARK 470 ARG B 222 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 223 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 236 CG CD CE NZ REMARK 470 GLU B 270 CG CD OE1 OE2 REMARK 470 ASN B 277 CG OD1 ND2 REMARK 470 ARG B 279 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 294 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B 298 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 GLN B 189 N11 UED B 401 1.36 REMARK 500 NE2 GLN B 189 C9 UED B 401 2.01 REMARK 500 NE2 GLN B 189 O8 UED B 401 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 177 CA - CB - CG ANGL. DEV. = -22.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -123.31 53.02 REMARK 500 HIS A 41 0.18 -68.76 REMARK 500 THR A 45 -111.38 -125.08 REMARK 500 GLU A 47 45.50 -79.24 REMARK 500 ASN A 51 99.63 -49.68 REMARK 500 ASN A 84 -124.18 53.99 REMARK 500 ASN A 277 10.01 -41.13 REMARK 500 LEU A 282 34.42 38.41 REMARK 500 ASP B 33 -128.78 53.09 REMARK 500 ASN B 84 -118.99 53.26 REMARK 500 TYR B 154 -110.96 56.92 REMARK 500 PRO B 184 41.94 -93.43 REMARK 500 GLN B 189 55.09 -93.03 REMARK 500 ASN B 277 59.75 -67.48 REMARK 500 REMARK 500 REMARK: NULL DBREF 8IG5 A 2 300 UNP P0C6U8 R1A_SARS 3242 3540 DBREF 8IG5 B 2 300 UNP P0C6U8 R1A_SARS 3242 3540 SEQRES 1 A 299 GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL GLU SEQRES 2 A 299 GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR LEU SEQRES 3 A 299 ASN GLY LEU TRP LEU ASP ASP THR VAL TYR CYS PRO ARG SEQRES 4 A 299 HIS VAL ILE CYS THR ALA GLU ASP MET LEU ASN PRO ASN SEQRES 5 A 299 TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS SER PHE SEQRES 6 A 299 LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE GLY SEQRES 7 A 299 HIS SER MET GLN ASN CYS LEU LEU ARG LEU LYS VAL ASP SEQRES 8 A 299 THR SER ASN PRO LYS THR PRO LYS TYR LYS PHE VAL ARG SEQRES 9 A 299 ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS TYR SEQRES 10 A 299 ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET ARG SEQRES 11 A 299 PRO ASN HIS THR ILE LYS GLY SER PHE LEU ASN GLY SER SEQRES 12 A 299 CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS VAL SEQRES 13 A 299 SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR GLY SEQRES 14 A 299 VAL HIS ALA GLY THR ASP LEU GLU GLY LYS PHE TYR GLY SEQRES 15 A 299 PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY THR SEQRES 16 A 299 ASP THR THR ILE THR LEU ASN VAL LEU ALA TRP LEU TYR SEQRES 17 A 299 ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN ARG SEQRES 18 A 299 PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA MET SEQRES 19 A 299 LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL ASP SEQRES 20 A 299 ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA VAL SEQRES 21 A 299 LEU ASP MET CYS ALA ALA LEU LYS GLU LEU LEU GLN ASN SEQRES 22 A 299 GLY MET ASN GLY ARG THR ILE LEU GLY SER THR ILE LEU SEQRES 23 A 299 GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN CYS SEQRES 1 B 299 GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL GLU SEQRES 2 B 299 GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR LEU SEQRES 3 B 299 ASN GLY LEU TRP LEU ASP ASP THR VAL TYR CYS PRO ARG SEQRES 4 B 299 HIS VAL ILE CYS THR ALA GLU ASP MET LEU ASN PRO ASN SEQRES 5 B 299 TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS SER PHE SEQRES 6 B 299 LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE GLY SEQRES 7 B 299 HIS SER MET GLN ASN CYS LEU LEU ARG LEU LYS VAL ASP SEQRES 8 B 299 THR SER ASN PRO LYS THR PRO LYS TYR LYS PHE VAL ARG SEQRES 9 B 299 ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS TYR SEQRES 10 B 299 ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET ARG SEQRES 11 B 299 PRO ASN HIS THR ILE LYS GLY SER PHE LEU ASN GLY SER SEQRES 12 B 299 CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS VAL SEQRES 13 B 299 SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR GLY SEQRES 14 B 299 VAL HIS ALA GLY THR ASP LEU GLU GLY LYS PHE TYR GLY SEQRES 15 B 299 PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY THR SEQRES 16 B 299 ASP THR THR ILE THR LEU ASN VAL LEU ALA TRP LEU TYR SEQRES 17 B 299 ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN ARG SEQRES 18 B 299 PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA MET SEQRES 19 B 299 LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL ASP SEQRES 20 B 299 ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA VAL SEQRES 21 B 299 LEU ASP MET CYS ALA ALA LEU LYS GLU LEU LEU GLN ASN SEQRES 22 B 299 GLY MET ASN GLY ARG THR ILE LEU GLY SER THR ILE LEU SEQRES 23 B 299 GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN CYS HET UED A 401 29 HET UED B 401 29 HETNAM UED N~2~-[(BENZYLOXY)CARBONYL]-N-{(2S)-1-HYDROXY-3-[(3S)-2- HETNAM 2 UED OXOPYRROLIDIN-3-YL]PROPAN-2-YL}-L-LEUCINAMIDE HETSYN UED GC373 BOUND FORM, GC376 BOUND FORM FORMUL 3 UED 2(C21 H31 N3 O5) FORMUL 5 HOH *56(H2 O) HELIX 1 AA1 SER A 10 GLY A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 THR A 45 MET A 49 5 5 HELIX 4 AA4 ASN A 53 ARG A 60 1 8 HELIX 5 AA5 SER A 62 PHE A 66 5 5 HELIX 6 AA6 ILE A 200 ASN A 214 1 15 HELIX 7 AA7 THR A 226 TYR A 237 1 12 HELIX 8 AA8 THR A 243 GLY A 258 1 16 HELIX 9 AA9 ALA A 260 GLY A 275 1 16 HELIX 10 AB1 THR A 292 GLN A 299 1 8 HELIX 11 AB2 SER B 10 GLY B 15 1 6 HELIX 12 AB3 HIS B 41 CYS B 44 5 4 HELIX 13 AB4 ASN B 53 ARG B 60 1 8 HELIX 14 AB5 SER B 62 HIS B 64 5 3 HELIX 15 AB6 ILE B 200 GLY B 215 1 16 HELIX 16 AB7 THR B 226 TYR B 237 1 12 HELIX 17 AB8 THR B 243 LEU B 250 1 8 HELIX 18 AB9 LEU B 250 GLY B 258 1 9 HELIX 19 AC1 ALA B 260 GLY B 275 1 16 HELIX 20 AC2 THR B 292 GLN B 299 1 8 SHEET 1 AA1 7 VAL A 73 LEU A 75 0 SHEET 2 AA1 7 LEU A 67 ALA A 70 -1 N ALA A 70 O VAL A 73 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N GLN A 19 O GLN A 69 SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O GLY A 29 N VAL A 18 SHEET 5 AA1 7 THR A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 AA1 7 LEU A 86 VAL A 91 -1 O LEU A 87 N CYS A 38 SHEET 7 AA1 7 VAL A 77 GLN A 83 -1 N SER A 81 O ARG A 88 SHEET 1 AA2 5 TYR A 101 PHE A 103 0 SHEET 2 AA2 5 VAL A 157 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA2 5 VAL A 148 ASN A 151 -1 N ASN A 151 O SER A 158 SHEET 4 AA2 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 AA2 5 SER A 121 ALA A 129 -1 O TYR A 126 N VAL A 114 SHEET 1 AA3 3 TYR A 101 PHE A 103 0 SHEET 2 AA3 3 VAL A 157 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA3 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165 SHEET 1 AA4 7 VAL B 73 LEU B 75 0 SHEET 2 AA4 7 PHE B 66 ALA B 70 -1 N VAL B 68 O LEU B 75 SHEET 3 AA4 7 MET B 17 CYS B 22 -1 N THR B 21 O LEU B 67 SHEET 4 AA4 7 THR B 25 LEU B 32 -1 O GLY B 29 N VAL B 18 SHEET 5 AA4 7 THR B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 AA4 7 LEU B 86 VAL B 91 -1 O LEU B 89 N VAL B 36 SHEET 7 AA4 7 VAL B 77 GLN B 83 -1 N GLY B 79 O LYS B 90 SHEET 1 AA5 5 TYR B 101 PHE B 103 0 SHEET 2 AA5 5 CYS B 156 GLU B 166 1 O PHE B 159 N LYS B 102 SHEET 3 AA5 5 VAL B 148 ASP B 153 -1 N ASN B 151 O SER B 158 SHEET 4 AA5 5 THR B 111 TYR B 118 -1 N SER B 113 O PHE B 150 SHEET 5 AA5 5 SER B 121 ALA B 129 -1 O TYR B 126 N VAL B 114 SHEET 1 AA6 3 TYR B 101 PHE B 103 0 SHEET 2 AA6 3 CYS B 156 GLU B 166 1 O PHE B 159 N LYS B 102 SHEET 3 AA6 3 HIS B 172 THR B 175 -1 O ALA B 173 N MET B 165 LINK SG CYS A 145 C21 UED A 401 1555 1555 1.77 LINK SG CYS B 145 C21 UED B 401 1555 1555 1.77 CISPEP 1 ASP A 153 TYR A 154 0 5.34 CRYST1 55.123 61.575 67.902 92.05 102.83 109.30 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018141 0.006352 0.004919 0.00000 SCALE2 0.000000 0.017207 0.002054 0.00000 SCALE3 0.000000 0.000000 0.015211 0.00000